164 related articles for article (PubMed ID: 36474139)
1. Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09.
Nirgude S; Desai S; Choudhary B
BMC Genomics; 2022 Dec; 23(1):807. PubMed ID: 36474139
[TBL] [Abstract][Full Text] [Related]
2. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract][Full Text] [Related]
3. ST08 Altered NF-κB Pathway in Breast Cancer Cells
Nirgude S; Desai S; Mahadeva R; Ravindran F; Choudhary B
Front Oncol; 2022; 12():835027. PubMed ID: 35615145
[TBL] [Abstract][Full Text] [Related]
4. Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.
Koroth J; Nirgude S; Tiwari S; Gopalakrishnan V; Mahadeva R; Kumar S; Karki SS; Choudhary B
BMC Complement Altern Med; 2019 Oct; 19(1):273. PubMed ID: 31638975
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.
Kalinkin AI; Sigin VO; Kuznetsova EB; Ignatova EO; Vinogradov II; Vinogradov MI; Vinogradov IY; Zaletaev DV; Nemtsova MV; Kutsev SI; Tanas AS; Strelnikov VV
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139172
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
7. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
8. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis.
Nirgude S; Desai S; Choudhary B
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1596. PubMed ID: 34981672
[TBL] [Abstract][Full Text] [Related]
9. Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells.
Ravindran F; Koroth J; Manjunath M; Narayan S; Choudhary B
Sci Rep; 2021 Nov; 11(1):23025. PubMed ID: 34837026
[TBL] [Abstract][Full Text] [Related]
10. Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study.
Chang LC; Hsieh MT; Yang JS; Lu CC; Tsai FJ; Tsao JW; Chiu YJ; Kuo SC; Lee KH
Int J Oncol; 2018 Jan; 52(1):67-76. PubMed ID: 29138806
[TBL] [Abstract][Full Text] [Related]
11. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
[TBL] [Abstract][Full Text] [Related]
12. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal.
Karousi P; Kontos CK; Papakotsi P; Kostakis IK; Skaltsounis AL; Scorilas A
Funct Integr Genomics; 2023 Sep; 23(4):299. PubMed ID: 37707691
[TBL] [Abstract][Full Text] [Related]
15. Endocan as a prognostic biomarker of triple-negative breast cancer.
Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
[TBL] [Abstract][Full Text] [Related]
16. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
17. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
[TBL] [Abstract][Full Text] [Related]
18. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
Liu Y; Zhou J; Hu Y; Wang J; Yuan C
Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
[TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes carboplatin treatment in triple negative breast cancer through reactive oxygen species induced DNA repair pathway.
Wang G; Duan P; Wei Z; Liu F
Mol Biol Rep; 2022 Apr; 49(4):3259-3270. PubMed ID: 35076853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
